Effectiveness of Artesunate and Amodiaquine for Malaria Treatment in Senegal
Author Information
Author(s): Philippe Brasseur, Patrice Agnamey, Oumar Gaye, Michel Vaillant, Walter RJ Taylor, Piero L Olliaro
Primary Institution: IRD, Dakar, Sénégal
Hypothesis
The study aims to evaluate the efficacy and safety of artesunate plus amodiaquine in treating uncomplicated malaria in a high transmission area.
Conclusion
Artesunate plus amodiaquine was found to be highly effective and well-tolerated for treating uncomplicated malaria in southern Senegal.
Supporting Evidence
- The overall cure rate was 94.6% across all years.
- Adverse events were reported in 7.1% of patients, with a low withdrawal rate of 0.9%.
- The study included a diverse population from various age groups.
Takeaway
This study shows that a combination of two medicines works really well to help people get better from malaria, and most people didn't have any bad reactions.
Methodology
The study involved treating malaria patients with artesunate plus amodiaquine and assessing their recovery over 28 days.
Potential Biases
Potential bias due to the non-comparative nature of the study and reliance on self-reported symptoms.
Limitations
The study did not include a control group and relied on observational data.
Participant Demographics
Participants included patients of all ages, with a mean age of 13.8 years, and a higher proportion of males.
Statistical Information
P-Value
<0.05
Confidence Interval
95% CI 92.9–95.9
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website